Results 1 to 10 of about 5,787 (90)

C38 - Évaluation in vitro de l'activité antibactérienne d'un pansement chargé d'extraits de plantes

Journal Africain de Technologie Pharmaceutique et Biopharmacie, 2023
Introduction : Les plaies infectées constituent un problème de santé publique du fait qu’elles peuvent prolonger la durée d’une hospitalisation. Les pansements utilisés dans leurs prises en charge contiennent souvent des antibactériens comme l’ion ...
M. DIOP, O. Thioune, C. Neut , M. Maton, C. Riviere, B. Martel, S. Mahieux, V. Roumy, N. Blanchemain, B. K. Fall   +9 more
doaj   +1 more source

C45 - Hydrogels oraux pH-sensibles contenant du phénobarbital pour une utilisation potentielle en pédiatrie

Journal Africain de Technologie Pharmaceutique et Biopharmacie, 2023
Introduction : Le but de l’étude était de développer des hydrogels oraux à base de chitosane pH- sensibles, capables de libérer le phénobarbital dans l'intestin grêle du nouveau-né.
Alphonse Rodrigue DJIBOUNE, Nicolas Anton, Sidy Mouhamed Dieng, Papa Mady Sy, Diouf Diouf, Gora Mbaye, Mamadou Soumboundou, Said Ennahar, Nadia Messaddeq, Thierry Vandamme, Mounibe Diarra   +10 more
doaj   +1 more source

C42 - Optimisation d’une formule de comprime matriciel à base de spiruline enrichi en vitamine C

Journal Africain de Technologie Pharmaceutique et Biopharmacie, 2023
La spiruline est une algue fortement consommée dans le monde comme complément alimentaire en raison de son grand potentiel nutritionnel. Elle se trouve toutefois exempte de vitamine C, une vitamine capitale pour le bon fonctionnement de l’organisme ...
Assogba Gabin ASSANHOU, Engelbert Janvier AGBOKPONTO, Habib GANFON, Urbain Comlan KASSEHIN, Virgile AHYI, Loconon Y. Achille YEMOA, Fernand A. GBAGUIDI   +6 more
doaj   +1 more source

Effect of in vitro gastrointestinal digestion on the chemical composition and antioxidant properties of Ginkgo biloba leaves decoction and commercial capsules

Acta Pharmaceutica, 2022
In this study Ginkgo biloba leaves (GBL) decoction and commercial capsules were digested using an in vitro model. Thirty-six active compounds were identified and quantified by HPLC-ESI-MS analysis based on the MS/MS patterns (precursor ions and product ...
Zhou Yubo, Yang Yingxin, Ma Minyan, Xie Lingyun, Yan Aijuan, Cao Wen   +5 more
doaj   +1 more source

Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study

Acta Pharmaceutica, 2022
A good therapeutic alliance is relevant for healthcare providers exposed to patients’ suffering, especially since patients and physicians may understand the painful experience differently.
Barrachina Jordi, Margarit César, Andreu Blanca, Zandonai Thomas, Ballester Pura, Muriel Javier, Cutillas Esperanza, Peiró Ana M.   +7 more
doaj   +1 more source

Optimized D-α-tocopherol polyethylene glycol succinate/phospholipid self-assembled mixed micelles: A promising lipid-based nanoplatform for augmenting the antifungal activity of fluconazole

Acta Pharmaceutica, 2022
Fluconazole (FLZ) is the most widely used antifungal agent for treating cutaneous candidiasis. Although oral FLZ has been proved to be effective, the incidence of side effects necessitates the development of an effective formulation that could surpass ...
Badr-Eldin Shaimaa M., Aldawsari Hibah M., Fahmy Usama A., Ahmed Osama A. A., Alhakamy Nabil A., Elfaky Mahmoud A., Sirwi Alaa, Hawsawi Salman A., Alzahrani Ali H., Yaseen Abdulrahman Y., Qassim Mohannad, Kotta Sabna   +11 more
doaj   +1 more source

Effects of tranquilization therapy in elderly patients suffering from chronic non-communicable diseases: A meta-analysis

Acta Pharmaceutica, 2023
The current meta-analysis searched the literature connected to different tranquilizers used to treat elderly people and assessed it in terms of dose, types of outcomes and adverse effects, to determine a safe and acceptable tranquilizer and its optimal ...
Li Jing, Li Jing, Cui Yulan, Li Honggeng, Hou Xiaoxuan, Zhao Fang, Zhao Qing, Zhao Junlan, Lin Pengchao   +8 more
doaj   +1 more source

The opposite effect of convulsant drugs on neuronal and endothelial nitric oxide synthase – A possible explanation for the dual proconvulsive/anticonvulsive action of nitric oxide

Acta Pharmaceutica, 2023
Nitric oxide (NO) participates in processes such as endothelium-dependent vasodilation and neurotransmission/neuromodulation. The role of NO in epilepsy is controversial, attributing it to anticonvulsant but also proconvulsant properties.
Vega Rasgado Lourdes A., Ramón-Gallegos Eva, Rodríguez-Páez Lorena, Alcántara-Farfán Verónica   +3 more
doaj   +1 more source

α1-Adrenoceptor agonist methoxamine inhibits base excision repair via inhibition of apurinic/apyrimidinic endonuclease 1 (APE1)

Acta Pharmaceutica, 2023
Methoxamine (Mox) is a well-known α1-adrenoceptor agonist, clinically used as a longer-acting analogue of epinephrine. 1R,2S-Mox (NRL001) has been also undergoing clinical testing to increase the canal resting pressure in patients with bowel incontinence.
Kohutova Aneta, Münzova Dita, Pešl Martin, Rotrekl Vladimir   +3 more
doaj   +1 more source

Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development

Acta Pharmaceutica, 2023
Chronic obstructive pulmonary disease (COPD) and lung cancer (LC) are closely related diseases associated with smoking history and dysregulated immune response. However, not all smokers develop the disease, indicating that genetic susceptibility could be
Baranasic Jurica, Niazi Yasmeen, Chattopadhyay Subhayan, Rumora Lada, Ćorak Lorna, Dugac Andrea Vukić, Jakopović Marko, Samaržija Miroslav, Försti Asta, Knežević Jelena   +9 more
doaj   +1 more source